Market expert Sanjiv Bhasin has suggested five stocks for investors and medium-term outlook traders for August in the pharmaceutical segment.

Glenmark Pharmaceuticals has received a notice from the Drugs Controller General of India (DGCI) regarding pricing of antiviral drug FabiFlu that has been effective is recovery of some COVID-19 pat

Gilead Sciences signed a contract with four Indian pharmaceutical companies to produce its medication ‘Remdesivir’ which has been found effective in treatment of some COVID-19 patients.

Pharmaceutical major Dr Reddy’s has reported 22 percent jump in profit before tax for fourth quarter and 10 percent growth in revenue.

Gilead Sciences CEO Daniel O’Day said on Friday that the company is focused on experimental coronavirus drug that is affordable and widely accessible.

Market analyst Ashwani Gujral is bullish for the day with five BUY Calls for stocks.